![Andrew Nebel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Andrew Nebel
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Duchenne UK
![]() Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Duchenne UK is a UK-based charity that focuses on finding effective treatments for Duchenne muscular dystrophy (DMD), a progressive condition that weakens all the muscles in the body and is diagnosed in childhood. Additionally, Duchenne connects and supports families affected by DMD. The charity funds research that aims to provide treatments for those affected by DMD and removes roadblocks that prevent patients from accessing the treatments they need. The British company was founded in 2012 by Nick Crossley, Emily Crossley, and Alex Johnson, and Emily Crossley and Alex Johnson have been the CEOs since 2012. | Voorzitter | - | - |
Loopbaan van Andrew Nebel
Eerdere bekende functies van Andrew Nebel
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Barnardo's
![]() Barnardo's Miscellaneous Commercial ServicesCommercial Services Barnardo's provides charitable services. The company was founded by Thomas John Barnardo in 1845 and is headquartered in Ilford, the United Kingdom. | Public Communications Contact | - | 01-07-2008 |
Verkoop & Marketing | - | 01-07-2008 |
Statistieken
Internationaal
Verenigd Koninkrijk | 3 |
Operationeel
Public Communications Contact | 1 |
Sales & Marketing | 1 |
Chairman | 1 |
Sectoraal
Commercial Services | 2 |
Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Barnardo's
![]() Barnardo's Miscellaneous Commercial ServicesCommercial Services Barnardo's provides charitable services. The company was founded by Thomas John Barnardo in 1845 and is headquartered in Ilford, the United Kingdom. | Commercial Services |
Duchenne UK
![]() Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Duchenne UK is a UK-based charity that focuses on finding effective treatments for Duchenne muscular dystrophy (DMD), a progressive condition that weakens all the muscles in the body and is diagnosed in childhood. Additionally, Duchenne connects and supports families affected by DMD. The charity funds research that aims to provide treatments for those affected by DMD and removes roadblocks that prevent patients from accessing the treatments they need. The British company was founded in 2012 by Nick Crossley, Emily Crossley, and Alex Johnson, and Emily Crossley and Alex Johnson have been the CEOs since 2012. | Miscellaneous |
- Beurs
- Insiders
- Andrew Nebel
- Ervaring